WHO ICTRP trial
Safety and efficacy of Diquas eye drops 3%
KCT0003134 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0003134 |
|---|---|
| Public title | Safety and efficacy of Diquas eye drops 3% |
| Scientific title | Post marketing surveillance on safety and efficacy of Diquas eye drops 3% in Korean patients in accordance with 'Regulation for re-examination of new drugs, etc." |
| Primary sponsor | Seoul National University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Diseases of the eye and adnexa |
| Interventions | Drug : Diquas 3% ophthalmic solution, six times a day, for more than 4 weeks, topical eye drop application |
| Registration date | Aug 28, 2018 |
| Target size | 70 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: